|
Exon 2
|
| Cys10Arg (p.Cys30Arg) |
Hungary/USA |
PN, H |
VO |
77 |
| Asp18Glu (p.Asp38Glu) |
USA |
PN, H |
VO, tortuous retinal vessels |
29, 78 |
| Val30Gly (p.Val50Gly) |
USA |
PN, LM, seizures |
VO, glaucoma, bilateral intermediate uveitis |
11,16 |
| Val30Met (p.Val50Met) |
Por, Japan, Swe |
Classic, predominant PN |
Full spectrum: KCS, pupillary ∆s, OAG, VO, conjunctival/retinal angiopathy |
26, 61, 76 |
| Phe33Ile (p.Phe53Ile) |
USA, J |
PN |
VO |
29, 36 |
| Phe33Val (p.Phe53Val) |
C, UK |
PN |
VO |
79 |
| Phe33Cys (p.Phe53Cys) |
Poland, USA |
PN, H, K |
VO (including as the first manifestation of FAP) |
80 |
| Arg34Gly (p.Arg54Gly) |
Kosovo |
PN, CTS |
VO: pseudopodia lentis; neovascular glaucoma |
72 |
| Lys35Thr (p.Lys55Thr) |
C, J |
PN, CTS, H |
VO81 |
|
| Ala36Pro (p.Ala56Pro) |
C, Gr, I, J, USA |
OMV, PN, deafness, strokes |
VO, retinal vasculitis, VH, early ocular disease |
55, 75, 82 |
| Trp41Leu (p.Trp61Leu) |
Russia, USA |
Skin disease, PN |
VO as the first symptom; posterior subcapsular cataract |
83 |
| Gly47Arg (p.Gly67Arg) |
USA, Italy |
PN, CTS, H, LM |
VO |
29 |
|
Exon 3
|
| Thr49Ala (p.Thr69Ala) |
Italy, France |
PN, H |
VO: pseudopodia lentis |
84 |
| Ser50Arg (p.Ser70Arg) |
Japan, Mexico |
PN, H |
Dry eyes in 18% |
85 |
| Gly53Ala (p.Gly73Ala) |
UK |
PN, H, K, LM, OM |
VO, retinal involvement |
86 |
| Glu54Gly (p.Glu74Gli) |
UK |
PN, H |
VO, spontaneous subconjunctival hemorrhages, retinal angiopathy |
29, 87 |
| Glu54Lys (p.Glu74Lys) |
Japan, Turkey |
PN, H |
VO |
88 |
| Leu55Arg (p.Leu75Arg) |
C, G |
PN, LM |
VO |
81 |
| Leu55Gln (p.Leu75Gln) |
Spain, Swe |
PN, H, CTS |
Glaucoma, VO, cataracts |
89 |
| Leu55Pro (p.Leu75Arg) |
C, D, G, USA |
Aggressive early PH, H |
KCS, INO, lacrimal gland amyloid deposits, pupillary ∆s, VO |
90 |
| Leu58Arg (p.Leu78Arg) |
Japan |
PN, H, CTS |
VO |
91 |
| Phe64Ser (p.Phe84Ser) |
Canada (I), UK |
LM, H, CNS, PN, deafness |
VO, blindness, Horner syndrome |
92 |
| Gly67Arg (p.Gly87Arg) |
Bangladesh |
PN |
KCS, VO (“glass-wool”), conjunctival angiopathy |
53 |
| Lys70Glu (p.Lys90Glu) |
Finland |
PN, CTS |
VO, secondary glaucoma, cataracts |
93 |
| Val71Ala (p.Val191Ala) |
France, Spain |
PN, H, K |
VO, retinal hemorrhages and angiopathy |
54 |
| Ser77Tyr (p.Ser97Tyr) |
France, G, USA |
PN, H, K |
Conjunctival lymphangiectasia |
65 |
| Gly83Arg (p.Gly103Arg) |
C (Han) |
PN, H |
VO (isolated initial presentation of FAP), glaucoma, xerophthalmia, dyscoria |
94, 95 |
| Ile84Ser (p.Ile104Ser) |
Hungary, S, USA |
PN, H |
VO |
96 |
| Glu89Lys (p.Glu109Lys) |
Japan |
PN, CTS, H |
KCS, VO, retinal microangiopathy, VH |
66 |
|
Exon 4
|
| Ile107Val (p.Ile127Val) |
Brazil, Japan, USA |
PN, H |
KCS |
42 |
| Tyr114Cys (p.Tyr134Cys) |
Japan, USA |
PN, LM, H, myopathy |
Pupillary ∆s, secondary glaucoma, KCS, VH, VO, conjunctival angiopathy, CRVO |
58, 69, 72 |